Metsera (MTSR) Hits New High on Billion-Dollar Bidding War
Earlier this year, Pfizer shelved a clinical trial for its own weight-loss drug candidate amid safety concerns and shifted its sights on acquiring Metsera, Inc. (NASDAQ:MTSR) to reenter the space.









